The Lancet Warns: Growing Evidence Demands Urgent Action on Endocrine Disruptors

Endocrine-disrupting chemicals are everywhere: in food packaging, personal care products, water supplies, and household dust. A 2020 review published in The Lancet Diabetes & Endocrinology surveyed the growing body of evidence published since 2016 and concluded that the case for urgent regulatory action has become substantially stronger. The chemicals in question, including bisphenols, phthalates, and perfluoroalkyl substances, mimic or interfere with the body's hormonal signaling at concentrations commonly found in the general population.

The evidence is particularly strong for specific health outcomes. Bisphenol A exposure has been linked to adult diabetes, reduced semen quality, and polycystic ovarian syndrome. Phthalates are associated with prematurity, reduced anogenital distance in boys (a marker of prenatal androgen exposure), childhood obesity, and impaired glucose tolerance. Perfluoroalkyl substances show connections to obesity in both children and adults, gestational diabetes, reduced birthweight, and breast cancer.

What makes endocrine disruptors particularly insidious is that they operate at low doses and over long exposure windows. Traditional toxicology assumes that higher doses produce greater effects, but endocrine disruptors often follow non-monotonic dose-response curves, meaning very low concentrations can trigger biological effects that higher concentrations do not. This challenges the regulatory frameworks built on conventional dose-response assumptions.

For individuals, reducing exposure is possible but requires awareness: minimizing plastic food contact, choosing fragrance-free products, filtering drinking water, and avoiding microwaving food in plastic containers. But individual action alone is insufficient without systemic regulatory change.

The Tracking Connection

Kairos™ helps users contextualize their hormonal health against known environmental risk factors. By tracking hormonal biomarkers over time alongside lifestyle and environmental data, Kairos can help identify whether unexplained hormonal shifts might correlate with environmental exposure patterns. When your data shows declining testosterone or rising insulin resistance without obvious lifestyle causes, environmental factors belong in the conversation, and Kairos ensures that conversation is grounded in data rather than speculation.